• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medication during pregnancy and breastfeeding is challenging for women with the condition. There aren't many studies regarding how exposure over time may affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems such as impaired hearing or vision, febrile seizures, or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Pregnant women who take ADHD medications must weigh the benefits of taking them against the potential risks to the foetus. Physicians don't have the data to make unambiguous recommendations, but can provide information on risks and benefits to assist pregnant women to make informed choices.

A study published in Molecular Psychiatry found that women who used ADHD medications during early pregnancy did not face a significantly increased risk of fetal heart malformations or major structural birth defects. Researchers used a vast population-based study of case-control to assess the risk of major structural birth defects in babies born to mothers who took stimulants during early pregnancy, as well as those who had not. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to confirm that the classification was correct and to minimize any bias.

However, the researchers' study had its limitations. The researchers were not able, in the first place to distinguish the effects triggered by the medication from the disorder. That limitation makes it difficult to determine whether the limited associations observed in the exposed groups are due to the use of medication or the confounding effect of comorbidities. The researchers did not look at long-term outcomes for offspring.

The study found that infants whose mother took ADHD medication during pregnancy were at a slightly higher chance of being admitted to the neonatal care unit (NICU) in comparison to those whose mothers didn't take any medication during pregnancy or quit taking the medication prior to or during pregnancy. This increase was due to central nervous system-related disorders, and the higher risk of admission did not appear to be influenced by the stimulant medication was used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher likelihood of having caesarean sections or a baby that scored low on the Apgar scale (less than 7). These risks did not appear to be affected by the type of medication that was used during pregnancy.

The research suggests that the small risk associated with the use of ADHD medications during early pregnancy could be offset by the greater benefit for both mother and child from continued treatment for the woman's disorder. Physicians should discuss this with their patients and, when possible, assist them in developing strategies for improving their coping skills which can reduce the effects of her disorder on her daily functioning and relationships.

Interactions with Medication

More and more doctors are confronted with the dilemma of whether to maintain treatment or stop during pregnancy as more women are diagnosed with ADHD. Most of the time, these decisions are taken in the absence of any evidence that is clear and definitive in either case, which means that doctors have to weigh their experience from their own experiences, those of other doctors, and what the research suggests on the subject, along with their own judgments for each individual patient.

The issue of potential risks to infants is extremely difficult. The research that has been conducted on this topic is based on observations rather than controlled studies, and the results are in conflict. In addition, most studies limit their analysis to live births, which can undervalue the serious teratogenic effects that can lead to abortion or termination of the pregnancy. The study that is discussed in this journal club addresses these shortcomings by analyzing data on live and deceased births.

The conclusion: While certain studies have demonstrated an association between ADHD medications and the risk of certain birth defects, other studies have not found any evidence of a link, and most studies show a neutral or even slightly negative impact. Therefore, a careful risk/benefit analysis must be done in each case.

For many women with ADHD, the decision to discontinue medication is difficult if not impossible. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of being isolated. Furthermore, a loss of medication can affect the ability to complete job-related tasks and drive safely which are essential aspects of a normal life for many people with ADHD.

She recommends women who are uncertain about whether to keep or stop medication in light of their pregnancy should consider the possibility of educating friends, family members, and coworkers on the condition, its effects on daily functioning, and on the advantages of staying on the current treatment regimen. In addition, educating them can help the woman feel supported as she struggles with her decision. It is important to note that some medications are able to pass through the placenta, so if the patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the drug could be transferred to the child.

Birth Defects and Risk of

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases there are concerns about what impact the medications could have on fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of information on this topic. Researchers used two massive datasets to analyze over 4.3 million pregnancy and determine if the use of stimulant medications increased the risk of birth defects. While the overall risk remains low, the scientists found that exposure in the first trimester to strongest adhd medication for adults medicines was associated with an increased risk of specific heart defects, such as ventriculoseptal defect (VSD).

The researchers behind the study found no connection between early medication use and other congenital abnormalities, like facial clefting, or club foot. The results are consistent with previous studies revealing the presence of a small, but significant increase in the risk of developing cardiac malformations among women who started taking ADHD medications before the birth of their child. This risk increased during the latter part of pregnancy, as many women are forced to stop taking their ADHD medications.

Women who were taking ADHD medication in the first trimester were more likely require a caesarean birth and also have a low Apgar after delivery, and had a baby that required breathing assistance after birth. The researchers of the study were not able to eliminate bias due to selection because they limited the study to women with no other medical conditions that could have contributed to the findings.

Researchers hope that their study will provide doctors with information when they meet pregnant women. They suggest that although a discussion of risks and benefits is important, the decision to stop or maintain medication must be based on each woman's requirements and the severity of her ADHD symptoms.

The authors warn that, while stopping the medication is an option to think about, it isn't recommended due to the high prevalence of depression and other mental problems among women who are pregnant or have recently given birth. Further, the research suggests that women who choose to stop their medications are more likely to experience difficulties adapting to life without them after the birth of their baby.

Nursing

The responsibilities of a new mom can be overwhelming. Women who suffer from ADHD can face severe challenges when they must manage their symptoms, attend doctor appointments and prepare for the birth of a baby and adjust to new routines. This is why many women choose to continue taking their ADHD medications throughout the course of pregnancy.

The risk for breastfeeding infant is minimal because the majority of stimulant medication is absorbed through breast milk at low levels. However, the amount of exposure to medications by the infant can my general practitioner prescribe adhd medication differ based on dosage, frequency it is administered, and the time of day the medication is administered. Additionally, different medications are introduced into the baby's system via the gastrointestinal tract, or through breast milk. The effect on the health of a newborn is not completely comprehended.

Some doctors may decide to stop stimulant medication during a woman’s pregnancy due to the absence of research. This is a complicated decision for the patient, who must weigh the benefits of continuing her medication with the potential risks to the fetus. As long as more information is available, doctors can ask pregnant patients whether they have a history of ADHD or if they plan to take medication in the perinatal phase.

Many studies have shown that women can continue to take their ADHD medication without risk during pregnancy and breast-feeding. This has led to more and more patients choose to do so and in consultation with their physician, they have discovered that the benefits of continuing their current medication far outweigh any risks.

It's important for women with ADHD who are contemplating breastfeeding to seek out a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss their medication for inattentive adhd with their doctor as well as the pros and cons for continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also necessary to help pregnant women with ADHD understand the symptoms and underlying disorder. They should also learn about treatment options and reinforce strategies for coping. This should be a multidisciplinary approach with the GPs, obstetricians, and psychiatrists. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and child, monitoring of indicators of deterioration, and, if necessary modifications to the medication regimen.